Utama › Kanser Prostat › Mississippi
Kajian klinikal Kanser Prostat di Mississippi
7 kajian untuk Kanser Prostat sedang mencari peserta di lokasi di Mississippi.
Bandar di Mississippi
Teks kajian rasmi (Bahasa Inggeris)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- University of Mississippi Medical Center, Jackson
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- Baptist Memorial Hospital and Cancer Center-Oxford, Oxford
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 19 Ogo 2026 · NCT04423211Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- University of Mississippi Medical Center, Jackson
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 14 Jul 2026 · NCT06592924Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- University of Mississippi Med Ctr, Jackson
Mengambil pesertaFasa 4
Umur 18 hingga 100 · Lelaki · Dikemas kini 4 Jun 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Mississippi Medical Center, Jackson
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Lelaki · Dikemas kini 22 Mei 2026 · NCT03151629Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- University of Mississippi Medical Center, Jackson
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 22 Jan 2026 · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hattiesburg
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.